Karolin Falconer

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Homie Razavi, Imam Waked, Christoph Sarrazin et al. · Journal of Viral Hepatitis · 2014 · 484 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16

Strategies to manage hepatitis<scp>C</scp>virus (<scp>HCV</scp>) disease burden

Heiner Wedemeyer, A.‐S. Duberg, Marı́a Buti et al. · Journal of Viral Hepatitis · 2014 · 181 citations · Full text

Pharmacy, Infectious Disease Control, Infectious Diseases +13

High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin Treatment

Verónica González, Karolin Falconer, Kim Blom et al. · Journal of Virology · 2009 · 148 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Expansion of Functionally Skewed CD56-Negative NK Cells in Chronic Hepatitis C Virus Infection: Correlation with Outcome of Pegylated IFN-α and Ribavirin Treatment

Veronica D. Gonzalez, Karolin Falconer, Niklas K. Björkström et al. · The Journal of Immunology · 2009 · 147 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Long‐Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver‐Related Outcomes

Habiba Kamal, Gabriel Westman, Karolin Falconer et al. · Hepatology · 2020 · 126 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14